Hydroxychloroquine, <scp>COVID</scp>‐19 and diabetes. Why it is a different story
Anca Pantea Stoian, Doina Catrinoiu, Manfredi Rizzo, Antonio Ceriello
Abstract
Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.
Topics & Concepts
HydroxychloroquineCoronavirus disease 2019 (COVID-19)Diabetes mellitusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineAction (physics)2019-20 coronavirus outbreakVirologyIntensive care medicineInternal medicineDiseaseEndocrinologyInfectious disease (medical specialty)Quantum mechanicsOutbreakPhysicsCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsDrug-Induced Ocular Toxicity